000 | 01744 a2200397 4500 | ||
---|---|---|---|
005 | 20250514161315.0 | ||
264 | 0 | _c20040312 | |
008 | 200403s 0 0 eng d | ||
022 | _a1527-6465 | ||
024 | 7 |
_a10.1053/jlts.2003.50268 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWiesner, Russell H | |
245 | 0 | 0 |
_aReport of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. _h[electronic resource] |
260 |
_bLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society _cNov 2003 |
||
300 |
_aS1-9 p. _bdigital |
||
500 | _aPublication Type: Consensus Development Conference; Journal Article; Review | ||
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 |
_aLiver Cirrhosis _xsurgery |
650 | 0 | 4 |
_aLiver Transplantation _ximmunology |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aReoperation |
650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aSorrell, Michael | |
700 | 1 | _aVillamil, Federico | |
773 | 0 |
_tLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society _gvol. 9 _gno. 11 _gp. S1-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/jlts.2003.50268 _zAvailable from publisher's website |
999 |
_c14328171 _d14328171 |